Kayla Kawamura, | |
Wai'anae &, Ayres Ave, Wahiawa, HI 96786-9678 | |
(808) 358-0041 | |
Not Available |
Full Name | Kayla Kawamura |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | Wai'anae &, Ayres Ave, Wahiawa, Hawaii |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922692334 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Provider Name | University Clinical Education & Research Associates |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1013966845 PECOS PAC ID: 1658275847 Enrollment ID: O20031120000276 |
News Archive
The adverse health effects caused by fine particles have been known for some time. In addition, ultrafine particles appear to play a significant role in cardiac function - even if an individual is exposed to these for only a few minutes, as scientists of Helmholtz Zentrum München have now been able to show.
Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.
The Queensland Government has announced $1 million a year over three years for new autism centers in Bundaberg and Mackay. These will provide care and also early intervention services to the substantial number of autistic children in the region.
In this interview, Rebekah Stibbs from EKF Diagnostics talks to News-Medical about eliminating the cold chain with COVID-19 molecular transport media.
Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Kayla Kawamura, 95-1116 Kualapa St, Mililani, HI 96789-4280 Ph: () - | Kayla Kawamura, Wai'anae &, Ayres Ave, Wahiawa, HI 96786-9678 Ph: (808) 358-0041 |
News Archive
The adverse health effects caused by fine particles have been known for some time. In addition, ultrafine particles appear to play a significant role in cardiac function - even if an individual is exposed to these for only a few minutes, as scientists of Helmholtz Zentrum München have now been able to show.
Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.
The Queensland Government has announced $1 million a year over three years for new autism centers in Bundaberg and Mackay. These will provide care and also early intervention services to the substantial number of autistic children in the region.
In this interview, Rebekah Stibbs from EKF Diagnostics talks to News-Medical about eliminating the cold chain with COVID-19 molecular transport media.
Protalix BioTherapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the Company's New Drug Application (NDA) for taliglucerase alfa for the treatment of Gaucher disease. Taliglucerase alfa is a plant-cell expressed form of glucocerebrosidase (GCD).
› Verified 8 days ago
Justin Guerrero Tano, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1684 Nakula St, Wahiawa, HI 96786 Phone: 808-220-2909 | |
Winona Lam, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1136 California Ave, Wahiawa, HI 96786 Phone: 808-485-5136 | |
Mrs. Janice Kuioka Cole, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 128 Lehua St, Wahiawa, HI 96786 Phone: 808-621-8411 | |
Mrs. Sandra Elizabeth Carlson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 330 Walker Ave, Wahiawa, HI 96786 Phone: 808-622-6329 |